Sharad Kumar Suthar

My research focuses on the design and development of new drug molecules, specifically targeting cancers, as well as compounds that interact with myosin-2 isoforms for various applications, including ischemic stroke, brain injury, neurological diseases and disorders, neuronal regeneration, and aging. Additionally, I have been actively involved in the isolation, structure elucidation, and pharmacophore optimization of natural products.